| Identification | Back Directory | [Name]
3'-TBDMS-Bz-rA Phosphoramidite | [CAS]
129451-75-8 | [Synonyms]
3'-TBDMS-Bz-rA Phosphoramidite
3'-TBDMS-rA(Bz) Phosphoramidite)
3'-TBDMS-Bz-rA Phosphoramidite, >97%
DMT-3'-O-TBDMS-A(Bz)-CE-Phosphoramidite
3'-O-TBDMS-5'-O-DMT-N6-Bz-rA CED phosphoramidite
5'-O-DMT-3'-O-TBDMS-N6-Benzoyl-Adenosine 2'-CE phosphoramidite
N6-Benzoyl-3'-O-tert-butyldimethylsilyl-adenosine 2'-CE phosphoramidite
N6-Benzoyl-3'-O-tert-butyldimethylsilyl-5'-O-DMT-adenosine 2'-CEphosphoramidite
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]adenosine 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethyl ethyl)dimethylsilyl]-, 2'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]
Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-, 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
(2R,3R,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
N-{9-[(2R,3R,4R,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-({[bis(propan-2-yl)amino](2-cyanoethoxy)phosphanyl}oxy)-4-[(tert-butyldimethylsilyl)oxy]oxolan-2-yl]-9H-purin-6-yl}benzamide
(2R,3R,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite(WXC08717) | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C53H66N7O8PSi | [MDL Number]
MFCD00274109 | [MOL File]
129451-75-8.mol | [Molecular Weight]
988.19 |
| Hazard Information | Back Directory | [Uses]
N6-Benzoyl-3''-O-tert-butyldimethylsilyl-5''-O-DMT-adenosine 2''-CE phosphoramidite is a nucleotide and adenosine (A280400) derivative used in the preparation of adenosine-inosine monophosphate (cAIMP) analogs that activate stimulator of interferon genes (STING). |
|
|